0 By Jo Gamble In Rest of the World, VICPosted September 15, 2023Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis (NEOS) READ MORE
0 By Jo Gamble In NSWPosted August 16, 2023People with mobility-impairing neurological conditions perspectives about graduated compression stockings to prevent deep vein thrombosis. READ MORE
0 By Jo Gamble In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted August 14, 2023Living Well with MS – Invisible Symptoms, Health Routines and Digital Technology READ MORE
0 By Jo Gamble In ACT, NSW, NT, NZ, QLD, SA, TAS, VIC, WAPosted May 30, 2023Designing Brain-Computer Interfaces for Individuals with Multiple Sclerosis READ MORE
0 By Jo Gamble In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted April 12, 2023Exploring the use and need for lifestyle management of multiple sclerosis READ MORE
0 By Tennille Luker In ACT, NSW, NT, NZ, QLD, SA, TAS, VIC, WAPosted January 9, 2023Project BASE: Changing Behaviour towards Aerobic and Resistance Exercise READ MORE
0 By Tennille Luker In NSW, QLD, TAS, VIC, WAPosted August 30, 2022A study to investigate the feasibility of smartphone-based self-monitoring to characterise cognitive and neurological impairment in participants with multiple sclerosis READ MORE
0 By Tennille Luker In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted August 3, 2022Investigating social cognitive factors associated with chronic non-cancer pain and pain management READ MORE
0 By Tennille Luker In QLD, VICPosted June 21, 2022An early feasibility study of the safety of an endovascular Motor Neuroprosthesis (MNP) in participants with severe upper limb dysfunction READ MORE
0 By Tennille Luker In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted June 16, 2022The Wellbeing Neuro Course: A Randomised Controlled Trial of an Online Treatment Program for Adults with Multiple Sclerosis READ MORE
